Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

280 results about "Class Mammalia" patented technology

Mammals (/ m ə ˈ m eɪ l i ə / from Latin mamma "breast") are vertebrate animals constituting the class Mammalia, and characterized by the presence of mammary glands which in females produce milk for feeding (nursing) their young, a neocortex (a region of the brain), fur or hair, and three middle ear bones.

Device features and design elements for long-term adhesion

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.
Owner:IRHYTHM TECHNOLOGIES INC

Device features and design elements for long-term adhesion

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.
Owner:IRHYTHM TECHNOLOGIES INC

Device features and design elements for long-term adhesion

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.
Owner:IRHYTHM TECHNOLOGIES INC

Device features and design elements for long-term adhesion

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.
Owner:IRHYTHM TECHNOLOGIES INC

Use of L-ergothioneine to ameliorate and prevent age-related vitreous degeneration

ActiveUS12168001B2Organic active ingredientsSenses disorderVitreous BodiesVitreous liquefaction
The present invention provides methods, compositions (e.g., eyedrop or spongarion composition), and uses for alleviating and preventing age-associated vitreous degeneration in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, polymer, analog or derivative thereof, as an active ingredient. In particular, L-ergothioneine is capable of scavenging chronic reactive oxygen species directly and radically to mitigate and prevent HA depolymerization and HA decreasing-viscosity in the mammal's vitreous body; and / or improving vitreous liquefaction in the mammal.
Owner:NANJING NUTRABUILDING BIO TECH CO LTD

Bio-Recharge System to Normalize Body Functions

PendingUS20250332434A1Light therapyDiseaseWhole body
The current invention provides a biocompatible energy recharge system to normalize body functions for a mammal. Both stationary and circulatory scalar wave energy was produced and utilized to enable the entire body of a mammal to increase the energy potential of any cell in the body, to promote cell growth, to facilitate cell repair, and to reduce cell destruction, hence the cells, organs, systems and the entire body of a mammal become healthy, and to treat a disease or disorder. The invention is a combination of the generators of the three-dimensional bio-waves in the stationary and in the circulationary formats for empowering the cells in all parts of a mammal, and a method of using the 3D bio-waves uniformly to empower each organ of a mammal to restore and maintain the normal body health and function.
Owner:TESLA BIOHEALING INC

Device features and design elements for long-term adhesion

An electronic device for long-term adhesion to a mammal includes a housing with an electronic component. The electronic device may include a first wing and a second wing, each being integrally formed with the housing. An electrode is positioned on a bottom surface of each of the wings, the electrodes electrically connected to the electronic component. An adhesive layer is provided for adhesion to a surface of the mammal. The adhesive layer may cover a portion of the bottom surfaces of the wings but generally does not cover the electrode or a bottom surface of the housing. A method of applying an electronic device to a mammal includes removing first and second adhesive covers from first and second wings of the electronic device to expose an electrode and an adhesive coated on a bottom surface of each wing.
Owner:IRHYTHM TECHNOLOGIES INC

Steerable device for use in mammal

The present invention relates to a steerable device (10) for use in a mammal, the steerable device (10) comprising an elongate element (12) and a flexible device tip (20), the device tip (20) comprising a tubular portion (22) and a plurality of permanent magnetic elements (30) arranged in the tubular portion (22). Each magnetic element (30) has an axial bore (40), and the axial bore forms an axial conduit (46) in which the core wire (50) extends. An axial bore (40) extends from a first axial end of the magnetic element to a second axial end opposite the first axial end. The first and second axial ends have ramps (79) allowing the magnetic elements (30) to move relative to each other, where the ramps (79) of the axial ends of adjacent magnetic elements are designed as circles having different radii or flat shapes having different angles with respect to the longitudinal axis to control bending of the device tip.
Owner:ETH ZURICH

Measuring device for the non-invasive determination of a blood glucose concentration in the body of a mammal

The invention relates to a measuring device for the non-invasive determination of a blood sugar concentration in the body of a mammal, comprising a housing (G), a measuring electronics (IC) in the housing (G), wherein the measuring electronics (IC) further comprises at least one transmitter (Tx) for emitting high-frequency signals with a frequency of more than 0.1 THz and less than 10 THz, at least one receiver (Rx) for receiving high-frequency signals with a frequency of more than 0.1 THz and less than 10 THz, wherein the at least one transmitter (Tx) is designed such that during operation it emits the high-frequency signal via an antenna (ANT_Tx) integrated in the measuring device, wherein the at least one receiver (Rx) is designed such that, during operation, it receives a high-frequency signal via an antenna (ANT_Rx) integrated in the measuring device, wherein the measuring device is configured to be attached relative to a nail plate (NP) on a nail of a finger or toe of the mammal, wherein the high-frequency signals from at least one transmitter (Tx) are coupled through the nail plate (NP) into the nail bed (NB) of the mammal during operation, and wherein the high-frequency signals backscattered from the nail bed (NB) of the mammal through the nail plate (NP) during operation are received by at least one receiver (Rx), wherein the measuring device further comprises an evaluation device (CPU) which is configured to evaluate the backscattered high-frequency signals received by at least one receiver (Rx) in order to determine the blood sugar concentration in the body of a mammal.
Owner:UNIV DUISBURG ESSEN

Device for determining the electric potential of the brain

A device for determining a physiological or psychological state of a mammal is disclosed. The device has at least one earpiece with a main body having a body of revolution with an axis of revolution, and an endpiece configured to be inserted into an ear canal. The endpiece has a cylindrical channel intended to receive a body of revolution for detachably mounting the endpiece on the main body, the endpiece being arranged to be movable in rotation about the axis of revolution in order to allow at least one electrode to be oriented toward a zone of the brain of the mammal, and the endpiece having a plurality of electrodes arranged on an outer surface of the endpiece, each electrode being configured to pick up an electrical signal in the ear canal of the mammal.
Owner:NAOX TECH

A vaccine for the treatment or prevention of burkholderia species infection in a subject.

PCT designated stage expiredWO2025036985A1Bacterial antigen ingredientsAntibacterial agentsBurkholderia speciesMicrobiology
A composition comprising BpPA26 is provided. The composition is for use in vaccine therapy to treat or prevent pathogenic Burkholderia species infection in a mammal, typically a human or an equine mammal. The species include Burkholderia cepacia complex, Burkholderia mallei, and Burkholderia pseudomallei.
Owner:UNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN

4-aminopyridine (4-AP) and bone morphogenetic protein 2 (BMP-2)

This document relates to methods and materials for using 4-aminopyridine (4-AP) and / or one or more derivatives of 4-AP. For example, a composition containing 4-AP and / or one or more derivatives of 4-AP can be administered (e.g., orally administered) to a mammal to increase a level of bone morphogenetic protein 2 (BMP-2) polypeptides within the mammal. For example, a composition containing 4-AP and / or one or more derivatives of 4-AP can be administered (e.g., orally administered) to a mammal having bone loss to increase the level of BMP-2 within the mammal, thereby treating the mammal's bone loss.
Owner:THE PENN STATE RES FOUND INC

Steerable device for use in body of mammal

The present invention relates to a steerable device (10) comprising an elongate element (12) configured to traverse through a mammalian body in a navigational manner. The elongate element (12) has a device tip (20) configured to allow manipulation of the elongate element (12) by an external magnetic field. Further, the device tip (20) comprises a plurality of segments (26), each segment (26) comprising a segment body (36) and a segment interface (38a, 38b), and a plurality of connectors (24), each connector (24) comprising a connector body (40) and a connector interface (42a, 42b). The connector interfaces (42a, 42b) and the segment interfaces (38a, 38b) each have complementary shapes to allow rotational movement relative to each other and to form a connection to maintain the connector and the segment in a mated state, and the magnetic element (34) at least partially forms the segment body or the connector body or both.
Owner:ETH ZURICH

Application of acting transmembrane protein in spermatogenesis period to diagnosis or treatment of male fertility defects

The present invention provides methods for diagnosing or predicting a fertility defect, such as infertility, in a mammalian subject by detecting Tmem232. The invention also provides kits and instruments for diagnosing or predicting fertility defects, such as infertility disorders, in mammalian individuals by detecting Tmem232. The invention finds and proves that sperm morphological abnormality and flagellum structure abnormality cause sperm motility abnormality and affect fertility of male mammals for the first time, thereby providing a method for diagnosing infertility of mammals including humans, and promoting development of a new treatment method for male infertility individuals affected by gene mutation.
Owner:SHANDONG UNIV

Non-rinsed veterinary compositions

PendingAU2020392433B2Ophiopogon japonicusSaccharide Isomerate
The invention relates to the veterinary field and, more particularly, non-rinsed compositions comprising an active ingredient obtained from Ophiopogon Japonicus, panthenol and saccharide isomerate, for non-human mammals. The invention also relates to a method for treating the fur of non-human mammals by applying said non-rinsed compositions to the fur and / or the skin.
Owner:CEVA SANTE ANIMALE SA

TRANSFER KIT FOR THE TRANSFER OF MATERIAL OR SUBSTANCE FOR REPRODUCTIVE, THERAPEUTIC OR DIAGNOSTIC PURPOSES, AND TRANSFER DEVICE INCLUDING THEM

The invention relates to a transfer assembly (1) intended to be integrated into a device suitable for transferring, into a female mammal, material or substance for reproductive, therapeutic or diagnostic purposes contained in the internal space of a straw, characterized in that the assembly (1) comprises: a protective sheath (5) having open proximal and distal ends (5b) and an internal axial conduit (50) extending between the proximal and distal ends (5b);and a connecting element (4) integral with the sheath (5) and introduced axially into the conduit (50), the connecting element (4) being a hollow body having open proximal (4a) and distal (4b) ends and a longitudinal passage (6) extending between the proximal (4a) and distal (4b) ends, the connecting element (4) comprising a proximal portion (40) intended to cooperate with the straw and a distal portion (41) intended to cooperate with the proximal end of an inner sheath of the device, the proximal portion (40) comprising means for retaining the straw. Figure to be published with the abbreviation: Figure 5.;
Owner:ELEXINN

Compositions and methods using a combination of nutrients to support cognition and emotional health in a mammal

PendingUS20250009687A1Nervous disorderKetone active ingredientsEmotional healthPhysiology
Compositions and methods can use at least one of (a) a combination of spermidine and ellagic acid or (b) a combination of docosahexaenoic acid (DHA) and curcumin to enhance cognition and emotional health in a mammal. The mammal is preferably an ageing or elderly human or an ageing or elderly companion animal, preferably an elderly dog.
Owner:SOCIETE DES PRODUITS NESTLE SA

Assessing and treating caveolinopathy diseases

PendingUS20250327799A1Muscular disorderDisease diagnosisRippling muscle diseaseDisease
This document relates to methods and materials involved in assessing and / or treating mammals having a caveolinopathy disease (e.g., immune-mediated rippling muscle disease (iRMD)). For example, methods and materials for detecting the presence of an autoantibody specific for a caveolae-associated protein 4 (cavin-4) polypeptide to identify a mammal as having iRMD as well as methods for treating a mammal identified having iRMD are provided. In some cases, cavin-4 polypeptides (and / or fragments thereof and / or variants thereof) can be used to detect the presence or absence of anti-cavin-4 polypeptide autoantibodies indicative of iRMD.
Owner:MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

Application of spermidine in preparation of preparation for improving fertility of female mammals

The invention discloses application of spermidine in preparation of a preparation for improving fertility of female mammals, and belongs to the technical field of reproductive biology. According to the invention, spermidine with different concentrations is introduced into mice, and the effect of spermidine on ovarian hormone secretion, ovarian reserve level and follicle number of female mammals is determined in a diet intake manner, so that the fertility of female animals is improved; it is found that spermidine can effectively improve the ovarian function, increase the secretion level of E2, P4, LH and AMH hormones closely related to the ovarian function, reduce the number of atresia follicles of the ovarian and increase the litter birth number of female mice by 1-2, and the spermidine has good animal breeding and livestock raising application prospects.
Owner:SICHUAN AGRI UNIV

Use of gnrh antagonist in regulation and control of estrus of mammal

PendingUS20260174707A1Organic active ingredientsPeptide/protein ingredientsMammalian reproductionPhysiology
The present invention relates to the field of mammalian reproduction and use of a GnRH antagonist in the regulation and control of estrus of a mammal. The GnRH antagonist can inhibit oestrus for a longer time with less frequent use, and can be used for estrus synchronization and batch reproduction of livestock husbandry animals or regulation and control of estrus of pets.
Owner:BEIJING VJT BIO CO LTD

Weight management composition

A method for promoting weight management in a mammal is provided, comprising administering to the mammal a weight loss agent and a mitochondria enhancing agent. Compositions for weight management are also provided.
Owner:EXERKINE CORP

Tunnel Filler Device And Methods Of Use

Devices and methods for treatment of a tunnel wound in a mammal are disclosed. A device can include a suture, a tunnel filler, and a cap member. The suture can be folded to form a proximal loop and two distal ends. The tunnel filler can be compressed onto the suture between the proximal loop and the two distal ends. And the cap member can be positioned on the suture distal to the tunnel filler. The tunnel filler can comprise decellularized mammalian extracellular matrix. The device can further include a tamp member positioned over the suture distal to the cap member. A method of treating a tunnel wound can include introducing the device into the tunnel wound, applying pressure to an end of the tunnel filler by sliding the tamp member along the suture, removing the tamp member from the suture, and securing an end of the suture to an end of the tunnel wound.
Owner:REPRISE BIOMEDICAL INC

A cage for assisting large animals to stand after surgery

The utility model discloses a cage for assisting large animals to stand after surgery, comprising a cage base, the four end corners of the lower end surface of the cage base are rotatably connected with universal pulleys, a drain plate is installed on the inner side of the cage base, a movable tray is slidably connected between the cage base and the drain plate, a handle is provided on the front end surface of the movable tray, a metal cage frame is fixedly installed on the upper end surface of the cage base, and blocking side doors are installed on both sides of the metal cage frame; a fixed frame is fixedly installed on the upper end surface of the metal cage frame, an upper sealing plate is fixedly installed on the inner side of the fixed frame, and an elastic abdominal support belt is installed between the fixed frame and the upper sealing plate. The utility model can effectively assist mammals to stand stably after surgery by using the cage to restrict the movements of mammals and lift their abdomens, avoid ischemic necrosis of the hind limbs when lying prone, and facilitate inspection and drug administration operations on mammals.
Owner:JIANGSU BOSAIFU MEDICAL TECH CO LTD

Epilepsy model

To provide a mammalian epilepsy model.SOLUTION: A mammalian epilepsy model is obtained by a method comprising (i) injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into three or more different brain or cranial nerve regions of a mammal; or (ii) injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into two or more different brain or cranial nerve regions of a mammal and injecting an RNA-interfering shRNA having a specific nucleic acid sequence of a nucleic acid encoding CREB-controlled transcriptional coactivator 1 into one or more different brain or cranial nerve regions of a mammal.SELECTED DRAWING: None
Owner:THE INSTITUTE OF PHYSICAL & CHEMICAL RESEARCH

Methods and compositions using dichrostachys glomerata to reduce anxiety, food cravings and stress and improve mood, physical health, mental health, energy and happiness in a mammal

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
Owner:KOTHARI SHIL